You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 3, MARCH 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Benefits of Isoniazid Chemoprophylaxis and Risk Factors for Tuberculosis Among Oglala Sioux Indians

Mayumi A. Mori, MD; Gary Leonardson, PhD; Thomas K. Welty, MD, MPH

Arch Intern Med. 1992;152(3):547-550.


Abstract

In a case-control study of 92 Indian patients, 46 with active tuberculosis (cases) and 46 tuberculin reactors without the disease (control subjects), significantly more control subjects than patients had prior adequate isoniazid chemoprophylaxis. While the Indian Health Service recommends treating all tuberculin reactors with isoniazid prophylaxis, most (75%) of our tuberculosis (TB) cases could have been prevented if the guidelines of the American Thoracic Society had been followed. Diabetes, alcohol abuse, and chronic renal failure were risk factors for active TB. Despite marked reductions in TB morbidity and mortality rates among American Indians and Alaska Natives over the past 30 years, their TB rates are still two to three times higher than overall United States and white rates. Enhanced TB control programs with an emphasis on preventive therapy for patients at risk for developing active disease, especially those with diabetes and chronic renal failure, could decrease the incidence and eventually eliminate TB among American Indians and Alaska Natives.

(Arch Intern Med. 1992;152:547-550)



Author Affiliations

From the Department of Pediatrics, Mt Sinai Medical Center, New York, NY (Dr Mori); the School of Medicine, University of South Dakota, Sioux Falls (Dr Leonardson); and the Epidemiology Program, Aberdeen Area Indian Health Service (Dr Welty), Rapid City, SD.


Footnotes

Accepted for publication October 14, 1991.

The opinions expressed in this article are those of the authors and do not necessarily represent those of the Indian Health Service. Reprint requests to the Office of Epidemiology, Public Health Service Indian Hospital, 3200 Canyon Lake Dr, Rapid City, SD 57702 (Dr Welty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tuberculous osteomyelitis in the diabetic foot
Rajeswaran et al.
British Journal of Diabetes & Vascular Disease 2005;5:289-291.
ABSTRACT  

Tuberculosis Among American Indians and Alaska Natives in the United States, 1993-2002
Schneider
AJPH 2005;95:873-880.
ABSTRACT | FULL TEXT  

Long-term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-up Study
Aronson et al.
JAMA 2004;291:2086-2091.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.